The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a survey of how the agency involves patients in its work.

The goal is to find out how patients would like the MHRA to communicate with them and how patients would prefer to communicate with the MHRA to raise concerns.

“We want to adopt a more systematic approach to listening to and involving patients — ensuring that the patient voice is heard when safety issues, concerning medicines or medical devices, are identified and in the licensing of new medicines,” the agency said.